NDSIB
WST icon

North Dakota State Investment Board’s West Pharmaceutical WST Stock Holding History

North Dakota State Investment Board’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$764K Buy
2,129
+37
+2% +$11.3K 0.03% 397
2026
Q1 		$524K Sell
2,092
-363
-15% -$90.3K 0.02% 456
2025
Q4 		$675K Buy
+2,455
New +$672K 0.03% 443

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

North Dakota State Investment Board's WST Position: Q2 2026 in Review

North Dakota State Investment Board increased its West Pharmaceutical (WST) stake by 1.8% in Q2 2026, buying an estimated $11.3K and bringing the position to 2,129 shares worth $764K. The position accounts for 0.03% of the portfolio, ranked #397.

North Dakota State Investment Board first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • North Dakota State Investment Board held 2,129 shares of West Pharmaceutical worth $764K as of Q2 2026.
  • North Dakota State Investment Board bought 37 West Pharmaceutical shares in Q2 2026, an estimated $11.3K.
  • West Pharmaceutical made up 0.03% of North Dakota State Investment Board's portfolio in Q2 2026, its #397 holding.
  • North Dakota State Investment Board first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.